Baumann, D., Hägele, T., Mochayedi, J., Drebant, J., Vent, C., Blobner, S., . . . Offringa, R. (2020). Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy. Nature Communications, 11, . https://doi.org/10.1038/s41467-020-15979-2
Chicago-Zitierstil (17. Ausg.)Baumann, Daniel, et al. "Proimmunogenic Impact of MEK Inhibition Synergizes with Agonist Anti-CD40 Immunostimulatory Antibodies in Tumor Therapy." Nature Communications 11 (2020). https://doi.org/10.1038/s41467-020-15979-2.
MLA-Zitierstil (9. Ausg.)Baumann, Daniel, et al. "Proimmunogenic Impact of MEK Inhibition Synergizes with Agonist Anti-CD40 Immunostimulatory Antibodies in Tumor Therapy." Nature Communications, vol. 11, 2020, https://doi.org/10.1038/s41467-020-15979-2.